Related Experiment Video

Updated: Jul 18, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Postmenopausal hypertension

L M Harrison-Bernard1, L Raij

  • 1Department of Physiology SL39, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112-2699, USA.

Current Hypertension Reports
|September 12, 2000
PubMed

Insights

Hormone replacement therapy (HRT) may benefit postmenopausal women with hypertension by potentially reducing blood pressure. Further research is needed to understand HRT

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Women's Health

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in women, with hypertension as a major risk factor.
  • Postmenopausal women experience a higher prevalence of hypertension compared to men after age 55.
  • Estrogen deficiency following menopause is linked to increased CVD risk.

Purpose of the Study:

  • To investigate the effects of hormone replacement therapy (HRT) on blood pressure in postmenopausal women with hypertension.
  • To explore the potential cardioprotective mechanisms of estrogen in vascular health.

Main Methods:

  • The study reviews existing literature on HRT, estrogen's vascular effects, and hypertension in postmenopausal women.
  • Analysis of experimental evidence regarding estrogen's modulation of nitric oxide and angiotensin pathways.

Main Results:

  • Hormone replacement therapy (HRT) has demonstrated potential in reducing cardiovascular disease incidence and blood pressure in some postmenopausal women.
  • Estrogen may exert cardioprotective effects through direct vascular actions and lipid profile improvements.
  • Loss of estrogen's vascular protection post-menopause may reveal a predisposition to hypertension.

Conclusions:

  • Further research is warranted to elucidate the specific effects of HRT on blood pressure in hypertensive postmenopausal patients.
  • Understanding estrogen's role in vascular regulation is crucial for managing hypertension and CVD in women.
  • HRT could be a potential therapeutic strategy for managing hypertension in this demographic.

More Related Videos

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Concept Videos

Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.